COMPASS Pathways plc (CMPS) Stock Price & Growth Analysis

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

COMPASS Pathways plc

CMPS

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

341M

Medical - Care Facilities

Next Earning date - 07 Aug 2025

341M

Medical - Care Facilities

Next Earning date - 07 Aug 2025

3.67USD

-0.04 ( -1.21%)

Market Closed (as of Jul 11, 20:00 EDT)

Relative Strenght

Volume Buzz

-48%

Earning Acce

Dist 52w H.

57%

Overview Chart

Quote Panel

Updated July 13, 2025

1W 11.18 % 1M -20.69 % 3M 21.85 % 1Y -48.31 %

Key Metrics

Market Cap
341.22M
Shares Outstanding
92.85M
Share in Float
84.17M
Dividende
0

Earning Date
07 Aug 2025
Price Target
3.675
Average Volume
2.44M
Beta
2.254

Range
2.25-8.537
Industry
Medical - Care Facilities
Website
https://compasspathways.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

0.00x

P/S Ratio

1.68x

P/B Ratio

0.1

Debt/Equity

0.0%

Net Margin

$-2.0

EPS

How CMPS compares to sector?

P/E Ratio

Fundamentals

Relative Strength

CMPS

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

CMPS

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$560K

NaN%

2026-Revenue

$1.49

-646%

2026-EPS

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

0.00(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

RBC Capital

initialise

Previous: Not converted

2024-07-22

Now: Outperform

Morgan Stanley

initialise

Previous: Not converted

2024-04-01

Now: Overweight

Earnings Growth

YoY

Current

Estimates

Q2.23

N/A

-0.62
vs -0.50

Q3.23

N/A

-0.67
vs -0.43

Q4.23

N/A

-0.53
vs -0.73

Q1.24

N/A

-0.55
vs -0.57

Q2.24

N/A

-0.56
vs -0.62

Q3.24

N/A

-0.56
vs -0.67

Q4.24

N/A

-0.63
vs -0.53

Q1.25

N/A

-0.44
vs -0.55

Q2.25

N/A

-0.43
vs -0.56

Q3.25

N/A

-0.39
vs -0.56

Sales Growth

YoY

Current

Estimates

Q4.22

NA vs NA

Q1.23

NA vs NA

Q2.23

NA vs NA

Q3.23

NA vs NA

Q4.23

3.7M vs NA

Q1.24

NA vs NA

Q2.24

NA vs NA

Q3.24

NA vs NA

Q4.24

-100%

NA vs 3.7M

Q1.25

NA vs NA

Return on Equity

QoQ

Q2.23

-17%

-0.17
vs -0.15

Q3.23

-13%

-0.13
vs -0.17

Q4.23

-15%

-0.15
vs -0.13

Q1.24

-14%

-0.14
vs -0.15

Q2.24

-17%

-0.17
vs -0.14

Q3.24

-20%

-0.20
vs -0.17

Q4.24

-28%

-0.28
vs -0.20

Q1.25

-9%

-0.09
vs -0.28

Institutionnal Ownership

QoQ

Q2.23

105

105
vs 108

-3%

Q3.23

123

123
vs 105

17%

Q4.23

134

134
vs 123

Q1.24

123

123
vs 134

-8%

Q2.24

131

131
vs 123

Q3.24

139

139
vs 131

Q4.24

136

136
vs 139

-2%

Q1.25

140

140
vs 136

Earnings Growth

Latest News

benzinga.com

8 hours ago

Vizsla Silver, COMPASS Pathways And Other Big Stocks Moving Lower In Monday's Pre-Market Session

invezz.com

8 hours ago

Compass Pathways stock slip as psilocybin depression trial falls short of expectations

proactiveinvestors.com

12 hours ago

Compass Pathways' late-stage psilocybin trial targeting treatment-resistant depression meets primary endpoint

zacks.com

13 hours ago

COMPASS Pathways (CMPS) Upgraded to Buy: Here's Why

seekingalpha.com

14 hours ago

Compass Pathways Stock: Downgrading To Hold On Released TRD Results With COMP360

businesswire.com

16 hours ago

Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET

Company Description

3.67USD

N/A

0.00x

1.68x

0.1

0.0%

$-2.0

$560K

$1.49

Earnings Growth

Latest News

Company Description

3.67USD

N/A

0.00x

1.68x

0.1

0.0%

$-2.0